Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease

Gang Li1, Ting Wang1, Jing Li2

  • 1Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Luzhou, Sichuan, China.

Insights

Serum growth differentiation factor-15 (GDF-15) is elevated in children with Kawasaki disease (KD), particularly those with coronary artery lesions (CALs) or non-response to treatment. GDF-15 predicts CALs and treatment outcomes in KD.

Area of Science:

  • Pediatrics
  • Immunology
  • Biochemistry

Background:

  • Kawasaki disease (KD) is an acute febrile illness affecting young children.
  • Coronary artery lesions (CALs) are a significant complication of KD.
  • Predicting CALs and treatment response in KD remains crucial.

Purpose of the Study:

  • To investigate serum growth differentiation factor-15 (GDF-15) levels in children with acute KD.
  • To evaluate GDF-15's role in predicting CALs and non-response to intravenous immunoglobulin (IVIG) therapy.
  • To compare GDF-15's predictive performance against established inflammatory markers.

Main Methods:

  • Serum samples were collected from 131 children with KD and 30 healthy controls before IVIG.
  • Serum GDF-15 concentrations were quantified using ELISA kits.
  • Univariate and multivariate logistic regression analyses were performed to assess associations with CALs and treatment response.

Main Results:

  • Serum GDF-15 levels were significantly higher in KD patients compared to healthy controls.
  • Elevated GDF-15 was observed in KD patients with CALs versus those without, and in non-responders versus responders.
  • GDF-15 showed positive correlations with white blood cell count, CRP, and ESR, and negative associations with albumin and pre-albumin.
  • GDF-15 independently predicted CALs and non-response to IVIG, outperforming CRP and ESR individually for CAL prediction.

Conclusions:

  • Serum GDF-15 concentrations are significantly elevated in acute KD, especially in cases with CALs and non-response to treatment.
  • GDF-15 serves as a valuable independent predictor for the development of CALs and treatment non-response in KD.
  • GDF-15 demonstrates potential as a superior or non-inferior biomarker for predicting CALs in KD compared to CRP and ESR.
Abstract

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K